{"categories":[],"author_url":"https://blog.hatena.ne.jp/macska/","height":"190","author_name":"macska","published":"2006-04-26 00:00:00","version":"1.0","blog_title":"*minx* [macska dot org in exile]","type":"rich","provider_name":"Hatena Blog","url":"https://macska.hatenadiary.org/entry/20060426/p1","image_url":null,"width":"100%","provider_url":"https://hatena.blog","description":"\u30cd\u30bf\u5143\u306e\u8ad6\u6587\u306f\u3053\u3061\u3089\uff1a Cosgrove L, Krimsky S, Vijayaraghavan M, Schneider L. 2006. \"Financial ties between DSM-IV panel members and the pharmaceutical industry.\" Psychotherapy and Psychosomatics. 75(3):154-160. Background: Increasing attention has been given to the transparency of potential conflicts of intere\u2026","blog_url":"https://macska.hatenadiary.org/","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fmacska.hatenadiary.org%2Fentry%2F20060426%2Fp1\" title=\"\u30a2\u30e1\u30ea\u30ab\u7cbe\u795e\u533b\u5b66\u4f1a\u300c\uff24\uff33\uff2d\u300d\u57f7\u7b46\u8005\u306e\u88fd\u85ac\u696d\u754c\u3068\u306e\u91d1\u92ad\u7684\u306a\u7e4b\u304c\u308a - *minx* [macska dot org in exile]\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","title":"\u30a2\u30e1\u30ea\u30ab\u7cbe\u795e\u533b\u5b66\u4f1a\u300c\uff24\uff33\uff2d\u300d\u57f7\u7b46\u8005\u306e\u88fd\u85ac\u696d\u754c\u3068\u306e\u91d1\u92ad\u7684\u306a\u7e4b\u304c\u308a"}